These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 569622)

  • 1. [Beneficial effects of contraceptive doses and large doses of medroxyprogesterone in the prevention and treatment of uterine hyperplasia].
    Bonte J
    Gynakol Rundsch; 1978; 18(3-4):172-82. PubMed ID: 569622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gynecological indications of a new progestational agent with prolonged action].
    Goisis M; Candotti G
    Minerva Ginecol; 1970 Mar; 22(6):339-67. PubMed ID: 5515153
    [No Abstract]   [Full Text] [Related]  

  • 3. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG
    Am J Obstet Gynecol; 1974 Oct; 120(4):537-48. PubMed ID: 4606673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Organization of republican endoscopic and cytologic centers for active screening of pretumor and tumor diseases of the cervical canal and corpus uteri].
    Mkrtchian LN; Ambartsumian AM; Arzumanian GA; Madoian AG; Shakhnazarian ZhS
    Vopr Onkol; 1988; 34(5):605-8. PubMed ID: 2968019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 6. [New technic of pre-surgical medical treatment of adenocarcinoma of the endometrium].
    Martella E; Torella M; Messalli EM; Quirino R
    Arch Ostet Ginecol; 1978; 83(3-4):81-91. PubMed ID: 757771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contraception using 3-monthly injections of Depo-Provera].
    Revaz C; Welti H; Dettling A
    Gynakol Rundsch; 1978; 18(3-4):183-92. PubMed ID: 569623
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
    Horger EO; Williamson HO; Hester LL
    J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 10. [MAP in the treatment of adenocarcinoma of the endometrium].
    Leone F; De Placido G; Frollo G
    Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Conservative organ-preserving measures in precancerous stages of endometrial cancer].
    Dallenbach-Hellweg G
    Gynakologe; 1988 Dec; 21(4):302-7. PubMed ID: 2974824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with progestational agents in the advanced phase of carcinoma of the endometrium. Study of 137 patients treated at the 1st division of obstetrics and gynecology of the San Camillo De Lellis Hospital in Rome].
    Rendina GM; Donadio C
    Minerva Ginecol; 1975 Dec; 27(12):1026-30. PubMed ID: 778677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of adenocarcinomas of the uterine body with medroxyprogesterone].
    Bonte J; Drochmans A; Lassance M
    Gynecol Obstet (Paris); 1966; 65(2):179-85. PubMed ID: 5942790
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
    Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
    Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contribution of the Italian gynecological clinics and obstetrical schools to the prevention of cancer of the uterus].
    Pescetto G; Spreafichi F
    Minerva Ginecol; 1970 Nov; 22(22):1116-22. PubMed ID: 5519147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medroxyprogesterone acetate treatment of a case of hyperadrenalism with adenocarcinoma of the endometrium].
    Lanza A; Fedele M; Di Gregorio A; Gagna G
    Minerva Ginecol; 1980 Apr; 32(4):259-66. PubMed ID: 7383431
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer-prevention examinations in the woman].
    Stoll P
    Fortschr Med; 1974 Mar; 92(9):369-72. PubMed ID: 4819505
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of clinical manifestations, treatment and possibilities in the prevention of cancer of the cervical stump].
    Vishnevskaia EE; Shinkevich IK; Shiriaeva AM
    Vopr Onkol; 1987; 33(11):82-5. PubMed ID: 3686929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.